http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104844560-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2425e03c2ac444c7ef5d68bb10d611cf |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D333-34 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D333-34 |
| filingDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8038a99529f55ad6313cea640e4213fd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5453ebed07f785147b61756d2f7f9321 |
| publicationDate | 2015-08-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104844560-A |
| titleOfInvention | (E)-3-hydroxy-5-(hydroxystyryl)thiophene-2-phenol sulfonate and preparation method and application thereof |
| abstract | The invention discloses a resveratrol derivative having the structural formula represented by the formula I. The invention also discloses a preparation method of the resveratrol derivative, and further discloses an application of the resveratrol derivative in preparation of drugs for treating breast cancer; the resveratrol derivative has the breast cancer cell MCF-7 inhibitory activity with the IC50 value reaching 43.4 [mu]M, and has a relatively strong inhibitory effect on breast cancer cells MCF-7. |
| priorityDate | 2015-04-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.